5 news items
Ionis, Biogen Down on Ending Development of ALS Drug
BIIB
HRTX
IONS
17 May 24
across multiple functional domains, including cognition, communication and motor function. Detailed data from this study will be presented
Merck Ends Keytruda Combo Melanoma Study Due to Futility
ANIP
LGND
MRK
14 May 24
with Keytruda monotherapy. Merck continues to analyze data from the study and will share the data with the scientific community and regulatory agencies
Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference
LGND
8 Apr 24
of excellence. We are proud of our land-grant mission of world-class education, groundbreaking research, and community-engaged outreach, and we are unified
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
AAN
AHCO
ALPP
27 Feb 24
24.2% to $0.7321. Earlyworks was selected as a co-creation partner for MetaMe® a meta-communication service utilizing cutting-edge technology from
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
ALDX
LGND
MRK
27 Feb 24
the FDA communicated that the Phase 3 DUPLEX study results alone are not sufficient to support an sNDA submission for an FSGS indication for FILSPARI
- Prev
- 1
- Next